Chemours Net Income vs. Operating Margin

CC Stock  USD 17.04  3.37  16.51%   
Based on Chemours' profitability indicators, Chemours Co may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Chemours' ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2012-12-31
Previous Quarter
60 M
Current Value
-61 M
Quarterly Volatility
206.9 M
 
Yuan Drop
 
Covid
 
Interest Hikes
At present, Chemours' Days Sales Outstanding is projected to increase slightly based on the last few years of reporting. The current year's Days Of Sales Outstanding is expected to grow to 48.59, whereas EV To Sales is forecasted to decline to 0.86. The current year's Net Income Per E B T is expected to grow to 1.46, whereas Accumulated Other Comprehensive Income is forecasted to decline to (256.2 M). At present, Chemours' Gross Profit Margin is projected to slightly decrease based on the last few years of reporting.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.250.1553
Way Up
Slightly volatile
For Chemours profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Chemours to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Chemours Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Chemours's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Chemours Co over time as well as its relative position and ranking within its peers.

Chemours' Revenue Breakdown by Earning Segment

Check out Trending Equities.
The next projected EPS of Chemours is estimated to be 0.6129 with future projections ranging from a low of 0.51 to a high of 0.68. Chemours' most recent 12-month trailing earnings per share (EPS TTM) is at -2.13. Please be aware that the consensus of earnings estimates for Chemours Co is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
 
Interest Hikes
Chemours is projected to generate 0.6129 in earnings per share on the 30th of June 2026. Chemours earnings estimates show analyst consensus about projected Chemours Co EPS (Earning Per Share). It derives the highest and the lowest estimates based on Chemours' historical volatility. Many public companies, such as Chemours, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Chemours Revenue Breakdown by Earning Segment

By analyzing Chemours' earnings estimates, investors can diagnose different trends across Chemours' analyst sentiment over time as well as compare current estimates against different timeframes.
Will Diversified Chemicals sector continue expanding? Could Chemours diversify its offerings? Factors like these will boost the valuation of Chemours. Projected growth potential of Chemours fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Chemours data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.65)
Dividend Share
0.513
Earnings Share
(2.13)
Revenue Per Share
38.659
Quarterly Revenue Growth
(0.05)
Understanding Chemours requires distinguishing between market price and book value, where the latter reflects Chemours's accounting equity. The concept of intrinsic value - what Chemours' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Chemours' price substantially above or below its fundamental value.
It's important to distinguish between Chemours' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Chemours should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Chemours' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Chemours Operating Margin vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Chemours's current stock value. Our valuation model uses many indicators to compare Chemours value to that of its competitors to determine the firm's financial worth.
Chemours Co is rated below average in net income category among its peers. It also is rated below average in operating margin category among its peers . At present, Chemours' Net Loss is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chemours' earnings, one of the primary drivers of an investment's value.

Chemours Operating Margin vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Chemours

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(386 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Chemours

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
(0.20) %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Chemours Operating Margin Comparison

Chemours is currently under evaluation in operating margin category among its peers.

Chemours Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Chemours, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Chemours will eventually generate negative long term returns. The profitability progress is the general direction of Chemours' change in net profit over the period of time. It can combine multiple indicators of Chemours, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-244 M-256.2 M
Operating Income-5 M-4.8 M
Income Before Tax-277 M-263.1 M
Total Other Income Expense Net-272 M-258.4 M
Net Loss-386 M-366.7 M
Income Tax Expense109 M92.9 M
Net Income Applicable To Common Shares77.4 M73.5 M
Net Income From Continuing Ops77.4 M73.5 M
Interest Income264.5 M191.6 M
Non Operating Income Net Other118.8 M70.6 M
Net Interest Income-237.6 M-249.5 M
Change To Netincome-11.5 M-12.1 M
Net Loss(2.57)(2.44)
Income Quality(0.68)(0.65)
Net Income Per E B T 1.39  1.46 

Chemours Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Chemours. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Chemours position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Chemours' important profitability drivers and their relationship over time.

Chemours Earnings Estimation Breakdown

The calculation of Chemours' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Chemours is estimated to be 0.6129 with the future projection ranging from a low of 0.51 to a high of 0.68. Please be aware that this consensus of annual earnings estimates for Chemours Co is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
0.51
Lowest
Expected EPS
0.6129
0.68
Highest

Chemours Earnings Projection Consensus

Suppose the current estimates of Chemours' value are higher than the current market price of the Chemours stock. In this case, investors may conclude that Chemours is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Chemours' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of June 2026Current EPS (TTM)
862.19%
0.0
0.6129
-2.13

Chemours Earnings History

Earnings estimate consensus by Chemours analysts from Wall Street is used by the market to judge Chemours' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Chemours' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Chemours Quarterly Gross Profit

153 Million

The current year's Retained Earnings Total Equity is expected to grow to about 2.6 B, whereas Retained Earnings are forecasted to decline to about 1.2 B. As of February 22, 2026, Common Stock Shares Outstanding is expected to decline to about 137.4 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 73.5 M.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chemours' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
13.8517.9522.05
Details
Intrinsic
Valuation
LowRealHigh
12.6916.7920.89
Details
Naive
Forecast
LowNextHigh
14.5118.6122.72
Details
10 Analysts
Consensus
LowTargetHigh
15.1716.6718.50
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Chemours assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Chemours. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Chemours' stock price in the short term.

Chemours Earnings per Share Projection vs Actual

Actual Earning per Share of Chemours refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Chemours Co predict the company's earnings will be in the future. The higher the earnings per share of Chemours, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Chemours Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Chemours, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Chemours should always be considered in relation to other companies to make a more educated investment decision.

Chemours Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Chemours' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
2026-02-05
2025-12-310.07740.05-0.027435 
2025-11-04
2025-09-300.240.2-0.0416 
2025-08-05
2025-06-300.460.580.1226 
2025-05-06
2025-03-310.20.13-0.0735 
2025-02-18
2024-12-310.160.11-0.0531 
2024-11-04
2024-09-300.280.40.1242 
2024-08-01
2024-06-300.570.38-0.1933 
2024-04-30
2024-03-310.180.320.1477 
2024-03-27
2023-12-310.250.310.0624 
2023-10-26
2023-09-300.690.63-0.06
2023-07-27
2023-06-301.071.10.03
2023-04-27
2023-03-310.470.980.51108 
2023-02-09
2022-12-310.08-0.6465-0.7265908 
2022-10-25
2022-09-301.041.240.219 
2022-07-28
2022-06-301.431.890.4632 
2022-05-02
2022-03-310.921.460.5458 
2022-02-10
2021-12-310.920.81-0.1111 
2021-11-04
2021-09-301.021.270.2524 
2021-07-29
2021-06-300.941.20.2627 
2021-05-03
2021-03-310.630.710.0812 
2021-02-11
2020-12-310.410.610.248 
2020-11-03
2020-09-300.330.470.1442 
2020-07-30
2020-06-300.10.180.0880 
2020-05-05
2020-03-310.460.710.2554 
2020-02-13
2019-12-310.420.560.1433 
2019-11-04
2019-09-300.590.590.0
2019-08-01
2019-06-300.860.72-0.1416 
2019-05-02
2019-03-310.90.63-0.2730 
2019-02-14
2018-12-310.991.050.06
2018-11-01
2018-09-301.421.490.07
2018-08-02
2018-06-301.591.710.12
2018-05-03
2018-03-311.221.410.1915 
2018-02-14
2017-12-310.971.190.2222 
2017-11-02
2017-09-301.041.120.08
2017-08-02
2017-06-300.850.870.02
2017-05-01
2017-03-310.50.750.2550 
2017-02-15
2016-12-310.290.350.0620 
2016-11-06
2016-09-300.340.610.2779 
2016-08-08
2016-06-300.170.270.158 
2016-05-02
2016-03-310.020.060.04200 
2016-02-23
2015-12-310.080.160.08100 
2015-11-05
2015-09-300.260.19-0.0726 
2015-08-06
2015-06-300.330.24-0.0927 

Use Chemours in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.

Chemours Pair Trading

Chemours Co Pair Trading Analysis

The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Chemours position

In addition to having Chemours in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Hedge Favorites Thematic Idea Now

Hedge Favorites
Hedge Favorites Theme
Hedge Funds pool capital from accredited individuals or institutional investors and invest in a variety of assets, often with complex portfolio-construction and risk-management techniques. The Hedge Favorites theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hedge Favorites Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
To fully project Chemours' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Chemours at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Chemours' income statement, its balance sheet, and the statement of cash flows.
Potential Chemours investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Chemours investors may work on each financial statement separately, they are all related. The changes in Chemours's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemours's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.